Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin as adjuvant therapy to interferon and ribavirin in chronic hepatitis C with HIV-1 coinfection
2006-006588-21Phase 2Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fluvastatin in hepatitis C virus infection and human immunodeficiency virus infection (HIV), sponsored by Luigi Sacco University Hospital. Primary endpoints: End-of-treatment virologic response and Sustained virologic response. Started May 2007; status: active.
02
Drugs
fluvastatin
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006588-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006588-21.